Delivery Order SPE2DB22D2211-SPE2DB25FSEFE
- Not listed
- The Defense Logistics Agency awarded a $7,533.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Veltassa is a potassium-binding medication used to treat hyperkalemia, a condition characterized by elevated potassium levels in the blood....
- The Defense Logistics Agency awarded a $4,074.30 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Veltassa 8.4 GM powder packets (30 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 31, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Veltassa 8.4 GM Powder Packet in a quantity of 30 units, with a ceiling value of $2,716.20. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM Powder Packet in quantities of 30, with a contract value of $8,148.60. Veltassa is a pharmaceutical treatment used in potassium management. This competitively awarded, firm fixed-price delivery order was executed on August 21, 2025, with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,052.60 delivery order to AmerisourceBergen Drug Corp for Veltassa 16.8 GM powder packets (30-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. Veltassa is a potassium-binding medication used in the treatment of hyperkalemia, a condition commonly requiring...
- The Defense Logistics Agency awarded a $2,565.83 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count units). This is a firm fixed-price contract with an ultimate completion date of August 26, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Veltassa 8.4 GM Powder Packet (30-count) with a ceiling value of $1,358.10. This is a firm fixed price delivery order with no set-aside designation, meaning the award was made through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,358.10 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Veltassa 8.4 gm powder packets (30-count units). This is a non-set-aside competitive award with an ultimate completion date of July 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,921.77 for VELTASSA 8.4 GM powder packets (30-count) on August 11, 2025, with completion scheduled for August 12, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a $5,636.48 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count). The contract, classified as firm fixed price with no set-aside designation, is scheduled for ultimate completion by July 28, 2025. This delivery order is performed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSEFEDelivery Order
The Defense Logistics Agency awarded a $1,424.40 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count). This is a firm fixed price contract with an ultimate completion date of September 5, 2025, and represents a non-set-aside, competitively awarded transaction. The contract is to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Veltassa is a potassium-binding agent used in the treatment of hyperkalemia, a condition characterized by elevated potassium levels in the blood. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion and extends through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its significant role as a critical pharmaceutical distributor for military and veteran healthcare systems, with consistent experience fulfilling delivery orders across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/4/25 |